High-dose chemotherapy (HDCT) with G-CSF support before radiotherapy (RT) in malignant gliomas (MG):: Phase II trial

被引:0
|
作者
Viñolas, N
Gil, M
Verger, E
Villá, S
Pujol, T
Caral, L
García, M
Graus, F
Estapé, J
机构
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Inst Catala Oncol, Barcelona, Spain
关键词
D O I
10.1016/S0959-8049(99)80869-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
435
引用
收藏
页码:S120 / S120
页数:1
相关论文
共 50 条
  • [31] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    R. I. Lalisang
    F. L. G. Erdkamp
    C. J. Rodenburg
    C. T. A. M. Knibbeler-van Rossum
    J. W. R. Nortier
    A. van Bochove
    P. H. Th. J. Slee
    E. E. Voest
    J. A. Wils
    J. Wals
    O. J. L. Loosveld
    A. E. M. Smals
    G. H. Blijham
    V. C. G. Tjan-Heijnen
    H. C. Schouten
    Breast Cancer Research and Treatment, 2011, 128 : 437 - 445
  • [32] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Garcia-Mata, Jesus
    Garcia-Palomo, Andres
    Calvo, Lourdes
    Mel, Ramon
    Cruz, Juan Jesus
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 739 - 744
  • [33] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Jesús García-Mata
    Andrés García-Palomo
    Lourdes Calvo
    Ramón Mel
    Juan Jesús Cruz
    Manuel Ramos
    Clinical and Translational Oncology, 2008, 10 : 739 - 744
  • [34] Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer
    H Wandt
    J Birkmann
    Th Denzel
    K Schäfer
    G Schwab
    D Pilz
    H Egger
    A Both
    WM Gallmeier
    Bone Marrow Transplantation, 1999, 23 : 763 - 770
  • [35] Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
    Halpern, Anna B.
    Othus, Megan
    Huebner, Emily M.
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Becker, Pamela S.
    Smith, Heather A.
    Oehler, Vivian G.
    Orozco, Johnnie J.
    Cassaday, Ryan D.
    Gardner, Kelda M.
    Chen, Tara L.
    Buckley, Sarah A.
    Orlowski, Kaysey F.
    Anwar, Asma
    Estey, Elihu H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (04) : E143 - E146
  • [36] Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells:: a phase I/II study in advanced ovarian cancer
    Wandt, H
    Birkmann, J
    Denzel, T
    Schäfer, K
    Schwab, G
    Pilz, D
    Egger, H
    Both, A
    Gallmeier, WM
    BONE MARROW TRANSPLANTATION, 1999, 23 (08) : 763 - 770
  • [37] A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients
    de Wit, R
    Kruit, WHJ
    Lamers, CHJ
    van't Veer, MB
    Luyten, AA
    van Beurden, V
    Harteveld, M
    Planting, AST
    Schmitz, PIM
    Stoter, G
    Bolhuis, RLH
    Verweij, J
    BRITISH JOURNAL OF CANCER, 1998, 77 (12) : 2363 - 2366
  • [38] A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients
    R de Wit
    WHJ Kruit
    CHJ Lamers
    MB van 't Veer
    AA Luyten
    V van Beurden
    M Harteveld
    ASTh Planting
    PIM Schmitz
    G Stoter
    RLH Bolhuis
    J Verweij
    British Journal of Cancer, 1998, 77 : 2363 - 2366
  • [39] Randomized comparison of G-CSF+GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy
    Spitzer, G
    Adkins, D
    Mathews, M
    Velasquez, W
    Bowers, C
    Dunphy, F
    Kronmueller, N
    Niemeyer, R
    McIntyre, W
    Petruska, P
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 921 - 930
  • [40] Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: Combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy
    Mizoe, Jun-Etsu
    Tsujii, Hirohiko
    Hasegawa, Azusa
    Yanagi, Tsuyoshi
    Takagi, Ryo
    Kamada, Tadashi
    Tsuji, Hiroshi
    Takakura, Kintomo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02): : 390 - 396